News
TCRT
2.960
+2.42%
0.070
Weekly Report: what happened at TCRT last week (0406-0410)?
Weekly Report · 1d ago
Weekly Report: what happened at TCRT last week (0330-0403)?
Weekly Report · 04/06 10:35
Ziopharm: Q4 Earnings Snapshot
Barchart · 03/31 17:46
Weekly Report: what happened at TCRT last week (0323-0327)?
Weekly Report · 03/30 10:35
Weekly Report: what happened at TCRT last week (0316-0320)?
Weekly Report · 03/23 10:31
Weekly Report: what happened at TCRT last week (0309-0313)?
Weekly Report · 03/16 10:30
Weekly Report: what happened at TCRT last week (0302-0306)?
Weekly Report · 03/09 10:31
BUZZ-U.S. STOCKS ON THE MOVE-Gitlab, ADT Inc, California Resources 
Reuters · 03/02 18:55
Weight Loss Data From Obese Mice Looks Promising For Alaunos Therapeutics, But Shares Drop
Benzinga · 03/02 16:47
BUZZ-U.S. STOCKS ON THE MOVE-Palantir Technologies, Cheniere Energy, Venture Global
Reuters · 03/02 16:04
BUZZ-U.S. STOCKS ON THE MOVE -Duolingo, AES, NextDecade
Reuters · 03/02 14:18
Alaunos Reports Positive Preclinical Data for Obesity Candidate
TipRanks · 03/02 12:20
BUZZ-U.S. STOCKS ON THE MOVE-Gold miners, energy firms, defense companies
Reuters · 03/02 12:16
BUZZ-Alaunos rises as obesity‑drug data in mice shows weight loss
Reuters · 03/02 11:44
Alaunos Therapeutics Announces Early Data From Two Non-GLP DIO Mouse Studies Evaluating ALN1003 For Treating Obesity And Related Conditions
Benzinga · 03/02 11:37
Alaunos Therapeutics reports positive preclinical proof-of-concept data for obesity drug ALN1003
Reuters · 03/02 11:31
ALAUNOS THERAPEUTICS INC - ANNOUNCES POSITIVE PRECLINICAL DATA FOR ALN1003 - SEC FILING
Reuters · 03/02 11:31
ALAUNOS THERAPEUTICS INC: CURRENT CASH RUNWAY EXTENDS INTO Q2 OF 2026
Reuters · 03/02 11:31
Alaunos Therapeutics reports positive preclinical obesity data for ALN1003 in DIO mice
Reuters · 03/02 11:30
Weekly Report: what happened at TCRT last week (0223-0227)?
Weekly Report · 03/02 10:30
More
Webull provides a variety of real-time TCRT stock news. You can receive the latest news about Alaunos Therapeutics, Inc through multiple platforms. This information may help you make smarter investment decisions.
About TCRT
Alaunos Therapeutics, Inc. is a pre-clinical obesity and metabolic disorder and clinical-stage oncology-focused cell therapy company. The Company focuses on developing small molecules that are expected to be efficacious against obesity and other metabolic disorders. The Company is engaged in developing novel small molecule-based obesity therapeutics. The Company’s operations consist primarily of conducting research and development and raising capital to fund those efforts. The Company has not generated any revenues.